Prior to moving to Buckingham, Jon worked in drug discovery in the pharmaceutical industry. He maintained a connection with the pharmaceutical industry through various consultancies and membership of scientific advisory boards. He has also been a governor (director) of a nutrition institute and a member of scientific advisory panels for two European Union research consortia. Research Jon’s long-standing interest has been in the regulation of energy expenditure in relation to the cause and treatment of obesity and type 2 diabetes. He has also published on the regulation of energy intake by the central nervous system, and other aspects of the regulation of energy balance and insulin sensitivity. Whilst most of his career has focused in metabolic disease, he spent six years working on novel bronchodilators for asthma.